Replimune Group, Inc. (REPL)
↓ Download CSVKey ratios (FY2025)
-59.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$261.63M | -$234.77M | -$177.08M | -$118.31M | -$79.95M | -$56.20M | -$30.95M | -$19.23M | -$9.65M |
| Net Income | -$247.30M | -$215.79M | -$174.28M | -$118.04M | -$80.87M | -$52.62M | -$30.83M | -$19.70M | -$7.70M |
| EPS (Diluted) | $-3.07 | $-3.24 | $-2.99 | $-2.26 | $-1.75 | — | — | — | — |
| Total Assets | $551.33M | $487.72M | $646.59M | $461.19M | $543.10M | $234.10M | $154.33M | $65.15M | — |
| Total Liabilities | $135.49M | $113.21M | $91.30M | $49.96M | $44.37M | $50.38M | $16.47M | $6.86M | — |
| Shareholders' Equity | $415.84M | $374.51M | $555.29M | $411.23M | $498.73M | $183.72M | $137.86M | -$28.07M | -$11.52M |
| Cash & Equivalents | $111.12M | $74.46M | $146.59M | $105.95M | $182.52M | $59.50M | $25.70M | $17.58M | — |
| Operating Cash Flow | -$192.25M | -$185.47M | -$128.05M | -$82.18M | -$61.39M | -$60.55M | -$25.38M | -$16.01M | -$7.08M |
| Capital Expenditures | $6.69M | $5.66M | $2.27M | — | — | — | — | — | — |
| Shares Outstanding | 77.09M | 61.42M | 56.68M | 47.34M | 46.57M | 36.67M | 31.66M | 5.01M | — |